Sanara MedTech Inc. (SMTI) Institutional Ownership

Ownership Summary

Sanara MedTech Inc. (NASDAQ:SMTI) is held by 50 institutional investors per 13F filings through December 2025.

• These investors collectively held 21.4% of Sanara MedTech's outstanding shares in December 2025, up from 12.9% in September 2025.
• Their total shares held in SMTI increased 80.98% from the prior quarter, while the number of investors in Sanara MedTech decreased 3.85% year over year.
• Of these 50 holders, 27 added to their stakes in Sanara MedTech, 16 trimmed positions, and 7 made no changes.
• Combined, these investors held 1.92Mn shares in SMTI for December 2025, up by 857.12K shares quarter on quarter, and up 939.34K shares year over year.
• As of December 31, 2025, the biggest holder of Sanara MedTech is BlackRock, Inc. at 228.77K shares, representing 2.56% of shares outstanding.
• The largest buyers of Sanara MedTech for the quarter ending December 2025 were VANGUARD CAPITAL MANAGEMENT LLC (151.37K), AQR CAPITAL MANAGEMENT LLC (39.94K), MARSHALL WACE, LLP (27.67K), RENAISSANCE TECHNOLOGIES LLC (27.08K), Qube Research & Technologies Ltd (26.41K).
• The largest sales of SMTI for the quarter ending December 2025 came from Baird Financial Group, Inc. (739.22K), HSBC HOLDINGS PLC (13.54K), Rockefeller Capital Management L.P. (11.2K), Morgan Stanley (8.59K), UBS Group AG (6.26K).
• Business Quant data shows the 10 biggest positions in Sanara MedTech as of December 2025 are held by BlackRock, Inc. (228.77K), VANGUARD CAPITAL MANAGEMENT LLC (151.37K), Stonebridge Wealth Management, LLC (136.9K), Royal Bank Of Canada (131.39K), GEODE CAPITAL MANAGEMENT, LLC (85.66K), MARSHALL WACE, LLP (76.28K), Squarepoint Ops LLC (73.61K), RENAISSANCE TECHNOLOGIES LLC (64.68K), State Street Corp (62.69K), AQR CAPITAL MANAGEMENT LLC (39.94K).